{
  "id": 11212669,
  "title": "Lilly pulls back from Foghorn's synthetic lethality work as biotech sheds 40% of staff",
  "url": "https://urgent.news/2026/10/01/lilly-pulls-back-from-foghorns-synthetic-lethality-work-as-biotech",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T14:14:59.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/lilly-pulls-back-from-foghorns-synthetic-lethality-work-as-biotech-sheds-40-of-staff/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Eli Lilly is walking away from Foghorn Therapeutics' \"synthetic lethality\" drug development, and the small biotech is reducing its headcount by 40% as a result of the culled collaboration. The duo is dropping a Phase ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}